Comparison of intranasal administration with intravenous injection of dexmedetomidine in postoperative pain control of mandibular fractures

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190325043107N40

Enrollment

Registered

2023-12-19

Start date

2024-01-19

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain intensity. Acute pain due to trauma

Interventions

Intervention 1: Intervention group: For the patients of this group (intranasal administration), this drug will be administered at the rate of 0.2 mcg/kg half an hour before the start of anesthesia (in

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with ASA class I, II candidate for mandibular fracture surgery Consent to participate in this research project

Exclusion criteria

Exclusion criteria: Patients with a history of high blood pressure Patients taking antihypertensive drugs Patients taking beta blockers Patients with a history of heart disease

Design outcomes

Primary

Measure	Time frame
Pain intensity. Timepoint: Every two hours for 24 hours after surgery. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Khanbabayi Gol

Tabriz University of Medical Sciences

Khanbabayimehdi69@gmail.com+98 41 3334 7054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026